• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

休克时消耗性凝血病的预防。肝素作用与抗凝血酶III活性的关系(作者译)

[Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].

作者信息

Bergmann H, Blauhut B, Necek S, Kramar H, Vinazzer H

出版信息

Anaesthesist. 1980 Nov;29(11):623-6.

PMID:7457802
Abstract

In 16 patients admitted in shock, heparin prophylaxis for DIC was carried out. The effect of heparin was monitored by a series of coagulation tests. A distinct relation was found between the effect of heparin on the aPTT and on the thrombin clotting time and the activity of antithrombin III. Even a comparatively slight diminution of this activity resulted in a considerable decrease of the heparin effect on coagulation. Since this effect is of primary importance for the efficacy of prophylaxis of DIC, regular assays of antithrombin III are proposed in shock patients receiving heparin.

摘要

对16例休克入院患者进行肝素预防弥散性血管内凝血(DIC)治疗。通过一系列凝血试验监测肝素的效果。发现肝素对活化部分凝血活酶时间(aPTT)和凝血酶凝血时间的作用与抗凝血酶III的活性之间存在明显关系。即使该活性相对轻微降低也会导致肝素对凝血的作用显著下降。由于这种作用对DIC预防效果至关重要,因此建议对接受肝素治疗的休克患者定期检测抗凝血酶III。

相似文献

1
[Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].休克时消耗性凝血病的预防。肝素作用与抗凝血酶III活性的关系(作者译)
Anaesthesist. 1980 Nov;29(11):623-6.
2
[Substitution of antithrombin III in shock and consumption coagulopathy].
Wien Klin Wochenschr. 1984 Dec 21;96(24):879-81.
3
[Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].抗凝血酶III的研究。II. 抗凝血酶III(ATIII)在控制弥散性血管内凝血(DIC)中的作用。(ATIII浓缩物在实验性DIC和临床DIC中的给药效果)(作者译)
Nihon Ketsueki Gakkai Zasshi. 1980 Oct;43(5):889-97.
4
[Substitution of antithrombin III in shock patients].
Anaesthesist. 1982 Jul;31(7):349-52.
5
[Antithrombin III substitution in patients in shock].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(6):806-16.
6
[Consumption coagulopathies following peritoneojugular bypass. Prevention by a heparin-antithrombin III combination].[经颈静脉肝内门体分流术后的消耗性凝血病。肝素-抗凝血酶III联合用药预防]
J Chir (Paris). 1986 Jun-Jul;123(6-7):417-23.
7
Coagulation and fibrinolysis in multiple trauma after early heparinizing.
Adv Shock Res. 1979;2:103-10.
8
[Use of antithrombin III concentrates].[抗凝血酶III浓缩物的应用]
Beitr Infusionsther. 1989;24:151-8.
9
The effect of prophylactic heparinization on DIC arising from transitory circulatory arrest in dogs.
Circ Shock. 1985;15(2):131-9.
10
Advanced neuroblastoma and disseminated intravascular coagulation: report of six cases.晚期神经母细胞瘤与弥散性血管内凝血:6例报告
Jpn J Clin Oncol. 1985 Sep;15(3):483-8.